Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06354010
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-02-20
Brief Title:
Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis
Sponsor:
Sensorion
Organization:
Sensorion
Study Overview
Official Title:
Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SONG
Brief Summary:
The purpose of this study is to characterize and assess the evolution of hearing impairment of patients with adulthood-onset bilateral sensorineural hearing loss carrying mutations on GJB2 gene
Detailed Description:
This study aims to characterize patients with adulthood-onset bilateral sensorineural hearing loss not due to any underlying medical condition likely due to a genetic cause and to assess the evolution of hearing impairment of those carrying mutations in GJB2 gene
Patients who present with adulthood-onset bilateral sensorineural hearing loss will be screened for the presence of mutation involved in hearing impairment Patients with GJB2 mutations will be proposed to continue in a follow-up period
Patients who present with adulthood-onset bilateral sensorineural hearing loss will be screened for the presence of mutation involved in hearing impairment Patients with GJB2 mutations will be proposed to continue in a follow-up period
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None